The World Triathlon Corporation (WTC) has announced that American age group athlete Kevin Moats will receive a one year period of ineligibility due to an adverse finding.
See the complete press release, originally posted on Ironman.com, below.
Today, World Triathlon Corporation (WTC) announced that an independent three member American Arbitration Association (AAA) panel issued its decision that American age-group athlete Kevin Moats committed a doping violation. Moats has received a one-year period of ineligibility for the offense, effective January 30, 2012, and has been provisionally suspended from WTC competition since notice of the adverse finding.
Moats, of Atlanta, Ga., was tested out-of-competition as part of the WTC Anti-Doping Program on January 30, 2012. The Adverse Analytical Finding resulted from the administration of testosterone consistent the World Anti-Doping Agency’s Prohibited List and by the World Triathlon Corporation Anti-Doping Rules (WTC Rules).
“This ruling makes it clear that all Age Group Athletes are accountable to the WTC Rules and the TUE requirements of their National Triathlon Federations (NF) and National Anti-Doping Organizations (NADO),” said Kate Mittelstadt, Director of Anti-Doping for WTC. “WTC has and will continue to work with all Anti-Doping Organizations to urge athletes to take seriously their responsibilities and obligations in anti-doping. We implore all athletes to check with their NF’s and NADO’s to determine if a TUE is necessary.”
“WTC has been a signatory to the World Anti-Doping Code (the Code) since 2005 and has had World Anti-Doping Agency recognized Code compliant rules since 2009,” continued Mittelstadt. “We take note of the panel’s recommendations regarding clarity and consistency of our Rules and will work with all our stakeholders and WADA to make any necessary changes to further ensure the effectiveness of the WTC Anti-Doping Program in protecting the principles of clean sport for our athletes and events.”
FILED UNDER: News